Dr. Pawan Goenka Continues as Independent Director at Sun Pharmaceutical Industries

Sun Pharmaceutical Industries Limited, India’s largest pharmaceutical company, has announced the re-appointment of Dr. Pawan Goenka as an Independent Director on its Board. This extension, effective from early 2026, ensures that the global pharma giant continues to benefit from the strategic oversight of one of India’s most respected industrial leaders. Dr. Goenka, widely known for his transformative leadership at Mahindra & Mahindra and his current role as Chairperson of IN-SPACe, brings a wealth of experience in R&D, manufacturing, and global scaling to Sun Pharma as it deepens its focus on specialty medicines and complex generics.